FROP-1 peptide-conjugated ultrasmall superparamagnetic nanoparticles as a targeted T1-weighted MR contrast agent for breast cancer: in vitro study
Abstract Background The aim of this study was to produce ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles (NPs) conjugated to the FROP-1 peptide for targeted magnetic resonance imaging (MRI) of breast cancer cell lines and to evaluate its application as a specific and targeted T1-weight...
Saved in:
| Main Authors: | Melika Samari, Zahra Alamzadeh, Rasoul Irajirad, Abolfazl Sarikhani, Vahid Pirhajati Mahabadi, Habib Ghaznavi, Samideh Khoei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Biomedical Engineering |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42490-025-00091-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rheological properties of superparamagnetic iron oxide nanoparticles
by: Javanbakht T., et al.
Published: (2021-08-01) -
Enhanced detection of glioblastoma vasculature with superparamagnetic iron oxide nanoparticles and MRI
by: Phillip W. Janowicz, et al.
Published: (2025-04-01) -
Cell-Based Therapies: Ferromagnetic Versus Superparamagnetic Cell Targeting
by: Tasneem Halhouli, et al.
Published: (2025-06-01) -
Production of novel theranostic nano-vector based on superparamagnetic iron oxide nanoparticles/miR-497 targeting colorectal cancer
by: Asmaa M. Elfiky, et al.
Published: (2025-02-01) -
SS-31 modification alleviates ferroptosis induced by superparamagnetic iron oxide nanoparticles in hypoxia/reoxygenation cardiomyocytes
by: Qizheng Lu, et al.
Published: (2024-10-01)